$121.26 -2.41 (%) Vertex Pharmaceuticals Inc - NASDAQ

Jan. 28, 2015 | 04:00 PM

Partner Headlines

  1. Vertex Pharmaceuticals Beats Q4 Revenue Expectations

    Benzinga | Jan. 28, 2015 | 17:39PM EST
  2. Earnings Scheduled For January 28, 2015

    Benzinga | Jan. 28, 2015 | 05:02AM EST
  3. 5 Big Biotech Earnings Releases To Watch This Week

    Benzinga | Jan. 26, 2015 | 14:34PM EST
  4. Vertex CEO On Company's New Cystic Fibrosis Drug, Pricing Strategy

    Benzinga | Jan. 14, 2015 | 10:40AM EST
  5. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  6. J.P. Morgan Chimes In With Ratings On BioTech Stocks

    GuruFocus | Jan. 6, 2015 | 12:46PM EST
  7. UPDATE: Barclays Capital Initiates Coverage On Vertex Pharmaceuticals On Leading Position In CF Market

    Benzinga | Jan. 6, 2015 | 10:24AM EST
  8. BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies

    Benzinga | Jan. 5, 2015 | 19:11PM EST
  9. 5 Biotech Stocks With Big News Due In January

    IBD | Dec. 31, 2014 | 13:15PM EST
  10. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus | Dec. 23, 2014 | 14:47PM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 22, 2014 | 08:18AM EST
  12. Don't Overlook Mid-Cap Stocks

    Benzinga | Dec. 11, 2014 | 18:14PM EST
  13. Great News For Biogen, But What's Next For The Stock?

    Benzinga | Dec. 3, 2014 | 12:36PM EST
  14. Weekly CFO Sells Highlight: Texas Instruments Inc, Royal Caribbean Cruises Ltd, Vertex ...

    GuruFocus | Nov. 9, 2014 | 15:20PM EST
  15. Bank Of America Is Impressed By Takeaways From Vertex Pharmaceuticals Conference Call

    Benzinga | Oct. 14, 2014 | 07:59AM EST
  16. UPDATE: Piper Jaffray Upgrades Vertex Pharmaceuticals Ahead Of Expected Combination Approvals

    Benzinga | Oct. 13, 2014 | 08:45AM EST
  17. Big Swings in Biotech Short Interest

    Benzinga | Oct. 13, 2014 | 08:32AM EST
  18. Piper Jaffray Upgrades Vertex Pharmaceuticals To Overweight

    Benzinga | Oct. 13, 2014 | 08:09AM EST
  19. H.C. Wainwright Highlights Its Top Picks Ahead Of NACFC 2014

    Benzinga | Oct. 1, 2014 | 10:15AM EST
  20. J&J Buying Alios, Going Up Against Gilead

    IBD | Sep. 30, 2014 | 12:02PM EST
  21. Fast Money Picks For September 26 - Pfizer Inc., The Dow Chemical Company And More

    Benzinga | Sep. 25, 2014 | 20:26PM EST
  22. Stocks End Skid; Vertex, Alexion Lead Biotech Rebound

    IBD | Sep. 24, 2014 | 16:16PM EST
  23. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 24, 2014 | 09:58AM EST
  24. These 3 Biotech Stocks Just Hit New Highs

    Benzinga | Sep. 22, 2014 | 13:31PM EST
  25. Midday Gainers From September 19 - Alibaba Group Holding Ltd, Concur Technologies, Inc. And More

    Benzinga | Sep. 19, 2014 | 14:13PM EST
  26. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD | Aug. 8, 2014 | 16:45PM EST
  27. Stocks Gain, Techs Take Lead; Autohome, BitAuto Top IBD 50

    IBD | Aug. 4, 2014 | 10:28AM EST
  28. Vertex Is Poised For An Earnings Breakout

    Benzinga | Jul. 23, 2014 | 15:56PM EST
  29. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD | Jul. 3, 2014 | 17:08PM EST
  30. Analyst Concerns On Vertex's Approved Drug

    Benzinga | Jun. 25, 2014 | 09:14AM EST
  31. Benzinga's Top Downgrades

    Benzinga | Jun. 25, 2014 | 08:00AM EST
  32. Vertex Soars On Drug Study

    IBD | Jun. 24, 2014 | 18:55PM EST
  33. Utility Sector Rises; Elizabeth Arden Shares Slide Over 3.6%

    Benzinga | Jun. 24, 2014 | 15:15PM EST
  34. Micron Gains On Upbeat Earnings; Elizabeth Arden Shares Slide

    Benzinga | Jun. 24, 2014 | 12:36PM EST
  35. Nasdaq Hits 14-Year High; Facebook Breaks Out

    IBD | Jun. 24, 2014 | 11:54AM EST
  36. Deutsche Bank Reiterates Buy on Vertex Pharmaceuticals Following Press Release

    Benzinga | Jun. 24, 2014 | 11:36AM EST
  37. Vertex Cystic Fibrosis Success Quells Street's Doubts

    IBD | Jun. 24, 2014 | 11:31AM EST
  38. Bernstein Weighs In On Vertex Move

    Benzinga | Jun. 24, 2014 | 10:58AM EST
  39. Benzinga's Volume Movers

    Benzinga | Jun. 24, 2014 | 10:41AM EST
  40. Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Misses Estimates

    Benzinga | Jun. 24, 2014 | 10:28AM EST
  41. Stocks Hitting 52-Week Highs

    Benzinga | Jun. 24, 2014 | 10:20AM EST
  42. Morning Market Movers

    Benzinga | Jun. 24, 2014 | 09:40AM EST
  43. Stocks Poised For Soft Start; Vertex Rockets In Premarket

    IBD | Jun. 24, 2014 | 09:00AM EST
  44. Why Are Vertex Pharmaceuticals Up More Than 50 Percent?

    Benzinga | Jun. 24, 2014 | 08:27AM EST
  45. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 24, 2014 | 08:07AM EST
  46. Indexes End With Small Gains; Tesla Drives Higher

    IBD | Jun. 16, 2014 | 16:25PM EST
  47. Vertex Shares Hit Hard On Trial Concerns

    Benzinga | Jun. 16, 2014 | 13:39PM EST
  48. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 16, 2014 | 08:16AM EST
  49. Health Care Sector in an Upward Climb in June

    GuruFocus | Jun. 12, 2014 | 16:21PM EST
  50. For The Record

    IBD | May. 2, 2014 | 18:58PM EST
Trading Center